Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Wake Forest University |
---|---|
Information provided by: | Wake Forest University |
ClinicalTrials.gov Identifier: | NCT00654355 |
The purpose of this research study is to better understand how the study drug works when people use it to treat atopic dermatitis.
Condition | Intervention | Phase |
---|---|---|
Atopic Dermatitis |
Drug: tacrolimus ointment |
Phase IV |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Single Group Assignment |
Official Title: | Measuring Adherence to Topical Therapy in Children With Atopic Dermatitis and the Impact of a Return Visit |
Estimated Enrollment: | 30 |
Study Start Date: | April 2008 |
Estimated Primary Completion Date: | September 2009 (Final data collection date for primary outcome measure) |
To evaluate adherence to topical therapy using adherence data collected by the MEMS cap (Medication Electronic Monitoring System) in pediatric patients with atopic dermatitis (AD) and the impact of a return visit.
Ages Eligible for Study: | 2 Years to 15 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Susie Dowd | 336-716-3775 | sdowd@wfubmc.edu |
United States, North Carolina | |
Dept of Dermatology, WFUHS | Recruiting |
Winston Salem, North Carolina, United States, 27157 | |
Contact: Adele Clark, PA-C 336-716-3775 adclark@wfubmc.edu | |
Principal Investigator: Steve R Feldman, MD, PHD |
Principal Investigator: | Steve Feldman, MD, PHD | WFUHS |
Responsible Party: | Wake Forest University Health Sciences ( Dr .Steve Feldman ) |
Study ID Numbers: | 00002300, contract #32417 |
Study First Received: | April 2, 2008 |
Last Updated: | January 9, 2009 |
ClinicalTrials.gov Identifier: | NCT00654355 History of Changes |
Health Authority: | United States: Institutional Review Board |
atopic dermatitis eczema |
Hypersensitivity Dermatitis, Atopic Immunologic Factors Genetic Diseases, Inborn Skin Diseases Hypersensitivity, Immediate |
Skin Diseases, Eczematous Tacrolimus Eczema Immunosuppressive Agents Skin Diseases, Genetic Dermatitis |
Dermatitis, Atopic Skin Diseases Immune System Diseases Immunologic Factors Physiological Effects of Drugs Tacrolimus Immunosuppressive Agents |
Pharmacologic Actions Hypersensitivity Genetic Diseases, Inborn Hypersensitivity, Immediate Skin Diseases, Eczematous Skin Diseases, Genetic Dermatitis |